UPL's long-term prospects remain positive, led by focus on branding and launching new innovative products, maintaining geographical presence , product and crop diversity, increasing share in the global agrochemical market, improving Innovation Turnover Index and consistently investing in backward as well as forward integration, resulting in better cost management. Acquisition of Arysta Life Sciences, a part of the US-based Platform Specialty Products, will make UPL the world's fifth largest crop protection company and the largest generic player with combined revenues of slightly lower than $4.6 billion . The company is currently the ninth largest with annual revenues of $2.7 billion. Further, given the strong manufacturing base of UPL, sourcing costs will be reduced as Arysta gets most of its raw materials from India and China. A strong supply chain can...